BOSTON– Flare Capital Partners, a leading healthcare technology venture capital firm, today announced the closing of its third fund, Flare Capital Partners III, L.P., with a total of $350 million in committed capital. The significantly oversubscribed fundraise follows up on its prior two funds raised in July 2019 and the inaugural fund raised in April 2015, respectively. With the most recent fund, this establishes Flare Capital Partners as one of the largest, independent, early-stage venture capital firms dedicated to healthcare technology.
The pandemic has caused the U.S. healthcare system to dramatically transform itself to respond to the many challenges confronting the appropriate and timely delivery of effective care. Indisputably, this healthcare crisis has been a massive accelerant for technology adoption as the healthcare system has to rapidly evolve as providers seek better clinical outcomes at lower costs, payers develop novel payment and engagement solutions, life sciences manufacturers embrace digital health and intelligent analytics solutions, employers look to improve the health of their covered populations at reasonable cost, and patients become more empowered proactive healthcare consumers. These needs are driving the demand for innovative models and technologies incorporating mobility and advanced analytics.
Flare Capital’s investment team is focused on transformational technologies and services that enable value-based healthcare, leveraging mobile solutions, big data analytics technologies, and secure infrastructure.
